NCLAT: Consideration of Debt Restructuring by Lenders Doesn’t Bar Member from Initiating Proceedings  ||  Delhi High Court: In Matters of Medical Evaluation, Courts Should Exercise Restraint  ||  Delhi HC: Any Person in India Has Right to Legally Import Goods from Abroad and Sell the Same  ||  Delhi HC: Waiver to Section 12(5) of Arbitration Act to be Given Once Tribunal is Constituted  ||  Supreme Court Has Asked States to Regularise Existing Court Managers  ||  SC: Union & States to Create Special POSCO Courts on Top Priority  ||  SC Upholds Authority of CERC to Award Compensation for Delays  ||  SC: Arbitral Tribunal Has Discretion to Include in Sum Awarded, Interest at Rate as it Deems Reasonab  ||  SC: Cannot Use Article 142 to Frame Guidelines on Judicial Recusal  ||  SC: Satisfaction Recorder in One EP Won’t Affect Subsequent EPs for Future Breaches    

Cabinet approves Memorandum of Intent (MoI) between India and Netherlands on cooperation in the field of Medical products Regulation- (Press Information Bureau) (18 Jan 2024)

MANU/PIBU/0094/2024

Civil

The Union Cabinet chaired by Prime Minister Shri Narendra Modi was apprised of a Memorandum of Intent (MoI) signed between the Central Drugs standard Control Organization (CDSCO), Ministry of Health and Family Welfare, Government of India and the Ministry of Health, Welfare and Sport, Kingdom of the Netherlands on behalf of Medicines Evaluation Board, Health and Youth Care Inspectorate, Central Committee on research Involving Human Subjects "on cooperation in the field of Medical products Regulation". The MoI was signed on 7th November, 2023.

The MoI seeks to establish a framework for fruitful cooperation and exchange of information between the Central Drugs Standard Control Organization (CDSCO) and the Ministry of Health, Welfare and Sport, Kingdom of the Netherlands on behalf of Medicines Evaluation Board, Health and Youth Care Inspectorate, Central Committee on Research Involving Human Subjects in matters relating to Medical products regulation in line with their International responsibilities.

The MoI between the regulatory authorities of the two countries will facilitate better understanding of medical products regulation with regard to pharmaceuticals including raw materials for pharmaceutical use, biological products, medical devices and cosmetic products.

Convergence in the regulatory practices could help in increasing export of medicines from India and consequentially help in better employment opportunities for educated professionals in the Pharmaceutical sector.

The MoI will facilitate export of medical products leading to foreign exchange earnings. This would be a step towards an Atmanirbhar Bharat.

Tags : MOI   MEDICAL PRODUCTS   APPROVAL  

Share :        

Disclaimer | Copyright 2025 - All Rights Reserved